Chitosan ameliorates the severity of steatohepatitis induced by high fat diet in rats
- 1 January 2008
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 43 (11) , 1371-1377
Abstract
Objective. Currently, no agent has been conclusively demonstrated to prevent the progression of non-alcoholic steatohepatitis (NASH). Chitosan, a natural product derived from chitin, was thought to possess hypocholesterolemic properties. The aim of this study was to evaluate the potential effects of chitosan on nutritional steatohepatitis in rats. Material and methods. Rats were fed with a high fat diet for 4 weeks to develop NASH that was confirmed by liver biopsy, and then 4 weeks of chitosan was given. Serum chemistry and liver histology were assessed and the steatoinflammatory mechanisms were studied. Results. Chitosan significantly protected against high fat diet-induced hepatic steatohepatitis. This effect was associated with repressed serum levels of total protein (TP), globulin (GLO), alanine aminotransferase (ALAT), alkaline phosphatase (ALP), γ-glutamyl transpeptidase (GGT), total cholesterol (TC) and low-density lipoprotein (LDL). Chitosan elevated the serum levels of high-density lipoprotein (HDL) and the ratio of albumin to globulin. Furthermore, increased TNF-α, lipoemia, hyperinsulinemia, hyperleptinemia and hypoadiponectin in NASH were significantly ameliorated by treatment with chitosan. Conclusions. Chitosan effectively attenuated the steatohepatitis induced by a high fat diet. The therapeutic effect of chitosan on NASH may be activated through exerting an influence on adipokines.Keywords
This publication has 18 references indexed in Scilit:
- EFFECTS OF SHRIMP (MACROBRACIUM ROSENBERGII)‐DERIVED CHITOSAN ON PLASMA LIPID PROFILE AND LIVER LIPID PEROXIDE LEVELS IN NORMO‐ AND HYPERCHOLESTEROLAEMIC RATSClinical and Experimental Pharmacology and Physiology, 2007
- Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitisScandinavian Journal of Gastroenterology, 2007
- Insulin resistance, adiponectin, cytokines in NASH: Which is the best target to treat?Journal of Hepatology, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- The role of leptin in progression of non-alcoholic fatty liver diseaseHepatology Research, 2005
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†Hepatology, 2005
- Is Adiponectin Involved in the Pathogenesis of Nonalcoholic Steatohepatitis?Journal of Clinical Gastroenterology, 2005
- Lipotoxic DiseasesAnnual Review of Medicine, 2002
- Metabolic and nutritional considerations in nonalcoholic fatty liverHepatology, 2000
- Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat dietInternational Journal of Obesity, 1999